Dr. Ilham Kadri

CEO and President of the Executive

Leadership Team of Solvay

Third Quarter 2023 results

Karim Hajjar

CFO of Solvay

November 3, 2023

Forenote

This presentation may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this presentation is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&D projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements.

Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

This document does not constitute an offer to sell, or the solicitation of an offer to subscribe for or buy, any securities.

page 2

Third quarter / First nine months 2023 Earnings

Nine Months 2023 performance

9.0 bn

2.3 bn

1.0 bn

15.2%

NET SALES

EBITDA

FCF

ROCE

-9.6%

-1.2%

%

-0.2pp

organic

organic

39

%

FCF

vs Q3 2022

-13% volumes

conversion

+4% pricing

25.9

EBITDA margin

page 3

Third quarter / First nine months 2023 Earnings

Delivering on project milestones

Shareholders' meeting

Full-year 2022 results

Q1 2023 results

Q2 2023 results

ELT and Board of directors announcements

November 3

Q3 2023 results

November 3

2022

Q1

Q2

Q3

Q4

2023

Webinars

Automotive/Batteries

Consumers

Peroxides

Webinars

Soda Ash

Aero & Defense

Completed social consultations Rating agencies published targets Branding of companies launched FSMA approval of registration documents

Capital structures

Registration document SCo Information document ECo

H1 key figures ECo & SCo

Debt management

Tax rulings

Capital Markets Day

November 13

Extraordinary Shareholders' meeting

December 8

Listing of Syensqo on Euronext Brussels/Paris

December 11

Third quarter and nine months 2023 results

This timetable is indicative and reflects a likely scenario. ECo and SCo are not reflective of the future company names.

Investing in sustainable growth

EssentialCo

Sale of energy supply business

  • Reduces Corporate costs volatility
  • Strengthens balance sheet

SpecialtyCo

Plan confirmed to build largest EV materials facility in USA

  • JV agreement with Orbia
  • Commitment to sustainable mobility

Third quarter / First nine months 2023 Earnings

Third quarter 2023 performance

2.7 bn

702 m

346 m

15.2%

NET SALES

EBITDA

FCF

ROCE

-20.3%

-18.5%

%

-0.2pp

organic

organic

39

%

FCF

vs Q3 2022

-15% volumes

conversion

-5% pricing

25.6

EBITDA margin

page 6

Third quarter / First nine months 2023 Earnings

Materials Q3 2023

Q3 2023 (€m)

% YoY

% YoY organic

Specialty Polymers

701

-17.8%

-12.5%

Composite Materials

258

-1.2%

+4.5%

Net Sales

959

-13.9%

-8.5%

EBITDA

324

-15.8%

-12.4%

EBITDA Margin

33.8% (-0.8pp)

Q3 Highlights

  • Sales in Specialty Polymers decreased due to lower volumes across most markets against a strong year-on-year comparison.
  • Organic sales in Composite Materials higher driven by sustained aerospace demand. Sales growth was impacted by supply chain issues which limited deliveries in the quarter.
  • EBITDA margin at remained strong at 33.8% or -0.8 percentage points versus last year

page 7

All figures rounded

Third quarter / First nine months 2023 Earnings Third quarter / First nine months 2023 Earnings

Solutions Q3 2023

Q3 2023 (€m)

% YoY

% YoY organic

Novecare

325

-36.3%

-31.4%

Special Chem

213

-18.2%

-14.1%

Techn. Solutions

159

-15.9%

-11.6%

Aroma Performance

82

-43.9%

-40.5%

Oil & Gas Solutions

103

-32.0%

-24.5%

Net Sales

882

-29.8%

-25.0%

EBITDA

164

-31.7%

-25.6%

EBITDA Margin

18.6%

(-0.5pp)

Q3 Highlights

  • Novecare sales were lower due to demand in agro, construction and consumer markets.
  • Special Chem came in lower due to lower volumes in electronics, partly offset by automotive, while prices were slightly positive year-on-year.
  • Technology Solutions sales decreased due to lower volumes in mining from temporary disruptions at certain mines, and slightly offset by higher prices.
  • Aroma Performance sales were down on continued lower demand and strong competition in the food, flavor & fragrance markets.
  • Oil & Gas sales decreased driven by lower drilling activity in the United States following the decline in natural gas prices and higher competitive pressure.
  • EBITDA margin slightly down year-on-year, but improving approximately 1 percentage point sequentially.

page 8

All figures rounded

Third quarter / First nine months 2023 Earnings Third quarter / First nine months 2023 Earnings

Chemicals Q3 2023

Q3 2023

(€m)

% YoY

% YoY organic

Soda Ash & Deriv.

478

-23.9%

-22.9%

Peroxides

149

-31.4%

-29.0%

Coatis

147

-34.7%

-36.6%

Silica

133

-18.9%

-17.2%

Net sales

908

-26.6%

-25.8%

EBITDA

274

-12.0%

-3.8%

EBITDA Margin

30.2%

(+5.0pp)

Q3 Highlights

  • Soda Ash & Derivatives sales lower due to reduced demand across most markets including construction, flat glass, and flue gas treatment. Prices were also lower as a result of lower energy costs.
  • Peroxides sales decrease driven by continued weak demand in some markets such as textiles, electronics and the pulp & paper market. Prices decreased following the normalization of energy prices compared to high levels last year.
  • Coatis sales lower due mainly to weak demand as well as competitive price pressure.
  • Silica sales lower mainly from volumes in the tire market while margins were sustained.
  • Lower variable and fixed costs more than offset the lower prices supported margin improvement in the quarter.

page 9

All figures rounded

Third quarter / First nine months 2023 Earnings Third quarter / First nine months 2023 Earnings

Structural cost reduction

2024 cost savings achieved 1.5 years ahead of time

Realized in FY 2020

175m

Realized in FY 2021

213m

Realized in FY 2022

79m

Realized YtD 2023

63m

Total costs savings to date

530m

Targeted annual run-rate by 2024

Permanent structural levers

  • Restructuring: ~50% of total
  • Indirect costs reductions: ~30%
  • Productivity efficiencies: ~20%

500m

page 10

Third quarter / First nine months 2023 Earnings

Third quarter / First nine months 2023 Earnings

Attachments

Disclaimer

Solvay SA published this content on 03 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2023 15:38:10 UTC.